Every so often, an industry emerges onto the investment stage that represents not only significant profit potential but also a tangible, positive impact on society. The fertility industry is one such sector, currently experiencing remarkable growth and showing no signs of slowing down.
Why fertility stocks have a positive outlook
The global in vitro fertilization market size is expected to reach USD 37.4 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to grow at a CAGR of 5.72% from 2023 to 2030.
In particular this growth is propelled by the increasing acceptance and use of In Vitro Fertilization (IVF). IVF is a procedure used to help with fertility and assist with the conception of a child. As a cornerstone of fertility treatments, it has seen substantial advancements and improved success rates over the years.
According to the World Health Organization (WHO) 1 in 6 people globally are affected by infertility. With global infertility rates on the rise, and more individuals and couples delaying parenthood for various reasons, IVF services are seeing a surge in demand.
These trends, combined with ongoing technological advancements in the fertility industry, makes the sector an enticing prospect for investors seeking both profitable and purposeful ventures.
Which fertility stocks are most promising?
Let’s dive into five of the most promising fertility stocks currently listed on the global stock market:
1. Vitrolife AB (VITR)
Sweden-based Vitrolife AB leads the global pack in the fertility sector. It is a comprehensive fertility solution provider offering products for in vitro fertilization (IVF) such as culture media, advanced time-lapse incubators, and quality systems.
Vitrolife has seen a consistent increase in its revenue, fuelled by its innovative solutions and market expansion. Its pioneering work in developing the EmbryoScope time-lapse system, a device that monitors the development of embryos and increases IVF success rates, has been a significant contributor to its growth.
Vitrolife is listed on the Stockholm Stock Exchange.
2. Progyny, Inc. (PGNY)
Based in the United States, Progyny is a leading benefits management company specializing in fertility and family building benefits solutions. This unique business model combines fertility treatments, including IVF and egg freezing, with ongoing patient support services, making the process easier and more successful for patients.
Progyny is investing heavily in its technology and patient support services, setting it up for potential growth in the coming years. Its stock has been on an upward trend since it went public in 2019, reflecting its strong position in the market.
Progyny is listed on the Nasdaq Stock Market.
3. Cooper Companies, Inc. (COO)
Cooper Companies, a global medical device company, has a significant presence in the fertility market through its CooperSurgical subsidiary. This segment provides a variety of products and services to fertility clinics, including IVF products, genetic testing services, and fertility clinic software.
The CooperSurgical division has been a growth driver for the company. Its unique positioning, offering a comprehensive range of solutions to fertility clinics, sets it up for strong future growth.
Cooper Companies is listed on the New York Stock Exchange.
4. Thermo Fisher Scientific Inc. (TMO)
Thermo Fisher Scientific, is a well-known global provider of various scientific research services, including fertility-related products. Their reproductive health segment offers a range of solutions from conception to delivery, making it a prominent player in the fertility market.
Thermo Fisher Scientific is listed on the New York Stock Exchange.
5. Illumina, Inc. (ILMN)
Illumina is a leader in the field of genetic sequencing. While not exclusively a fertility company, their advancements in preimplantation genetic screening (PGS) and preimplantation genetic diagnosis (PGD) have improved success rates in IVF procedures by detecting genetic abnormalities prior to implantation.
Illumina is listed on the Nasdaq Stock Market.
In Conclusion: The future is fertile
Investing in fertility stocks offers a unique opportunity to not only potentially profit from this growing market, but also contribute to a sector that is making a significant difference in many people’s lives.
In summary, this dynamic industry is characterized by its rapid expansion and its profound impact on society. Global infertility rates are climbing, the trend of delayed parenthood is deepening, and fertility and IVF technologies are continuously evolving, together, these factors stimulate an escalating demand for fertility services.
The diverse and innovative companies explored in this post, such as Vitrolife AB, Progyny, Inc., Cooper Companies, Inc., Thermo Fisher Scientific Inc., and Illumina, Inc., are leading the charge within this sector. For you as an investor, aligning with these industry front-runners offers the chance to participate in a sector that is not only witnessing remarkable financial growth but also championing a cause that resonates deeply with people worldwide.
Always make sure that your investments align with your investment strategy.
